{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:31:31Z","timestamp":1794472291521,"version":"4.9.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Brazilian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention in patients with acute coronary syndrome remains uncertain. This analysis examined the temporal patterns of ischaemic and bleeding risks of early aspirin withdrawal compared with DAPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NEO-MINDSET randomized 3410 acute coronary syndrome patients undergoing successful percutaneous coronary intervention with drug-eluting stents within 4 days of hospital admission to either potent P2Y12 inhibitor monotherapy (prasugrel or ticagrelor) or standard DAPT (aspirin plus a potent P2Y12 inhibitor) for 12 months. This prespecified landmark analysis examined early (0\u201330 days) and late (31\u2013365 days) follow-up events. Co-primary outcomes were (i) the composite of all-cause death, myocardial infarction, stroke, or urgent target-vessel revascularization (ischaemic outcome) and (ii) Bleeding Academic Research Consortium type 2, 3, or 5 bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 30 days, the composite ischaemic outcome occurred in 3.3% of patients receiving monotherapy vs 1.8% with DAPT (risk difference 1.5%, 95% confidence interval .4% to 2.6%; P = .006). Bleeding occurred in .6% vs 1.5% (risk difference \u2212.8%, 95% confidence interval \u22121.5% to \u2212.1%; P = .018). In the landmark analysis between Days 31 and 365, ischaemic outcome rates were similar between study groups (3.8% each; P = .977), while bleeding remained less frequent with monotherapy (1.3% vs 3.5%; risk difference \u22122.2%, 95% confidence interval \u22123.2% to \u22121.1%; P &amp;lt; .0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This prespecified 30-day landmark analysis suggests an excess of ischaemic risk with monotherapy vs DAPT in the first 30 days but not thereafter, whereas an aspirin-free strategy was consistently associated with fewer bleeding events within and after 30 days.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf1050","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:36:53Z","timestamp":1765802213000},"source":"Crossref","is-referenced-by-count":14,"title":["Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEO-MINDSET trial"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-3371","authenticated-orcid":false,"given":"Caio A M","family":"Tavares","sequence":"first","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]},{"name":"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia O","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Franken","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Santo","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy F A","family":"Prado","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe M T","family":"Bezerra","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagner","family":"Madrini-Junior","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]},{"name":"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willterson C","family":"Bandeira","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9lcio G S","family":"Junior","sequence":"additional","affiliation":[{"name":"Hospital Maria Aparecida Pedrossian, Universidade Federal do Mato Grosso , Mato Grosso do Sul ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Montenegro","sequence":"additional","affiliation":[{"name":"Centro de Pesquisa Cl\u00ednica do Instituto de Ensino Alberto Ferreira da Costa , Recife ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A R","family":"Forte","sequence":"additional","affiliation":[{"name":"Centro de Pesquisa Cl\u00ednica da PUCPR , Curitiba ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Alvarenga","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Passos , Passos ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"de Martino","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas da Universidade Federal do Tri\u00e2ngulo Mineiro , Uberaba ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos M","family":"Seki","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina da Universidade Estadual Paulista , Botucatu ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F K","family":"Saraiva","sequence":"additional","affiliation":[{"name":"Instituto de Pesquisa Cl\u00ednica de Campinas , Campinas ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil A","family":"Saad","sequence":"additional","affiliation":[{"name":"Hospital Fel\u00edcio Rocho , Belo Horizonte ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-5414","authenticated-orcid":false,"given":"Adriano","family":"Caixeta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universidade Federal de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L de A A","family":"Falc\u00e3o","sequence":"additional","affiliation":[{"name":"Hospital de Messejana Dr. Carlos Alberto Studart Gomes , Fortaleza ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimar K S","family":"Barroso","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Unidade de Hipertens\u00e3o Arterial, Universidade Federal de Goi\u00e1s , Goi\u00e1s ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C X","family":"Meireles","sequence":"additional","affiliation":[{"name":"Instituto de Assist\u00eancia M\u00e9dica ao Servidor P\u00fablico Estadual de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago B","family":"Dias","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Pedro Ernesto , Rio de Janeiro ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Monfardini","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia R L","family":"Assis","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C","family":"Nicolau","sequence":"additional","affiliation":[{"name":"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei C","family":"Sposito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medical Sciences, State University of Campinas , Campinas ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D","family":"Lopes","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University , Durham ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Galway , Galway ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[{"name":"Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Universit\u00e0 della Svizzera Italiana , Lugano ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J","family":"Angiolillo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Florida College of Medicine , Jacksonville, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W J C","family":"Serruys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Galway , Galway ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[{"name":"George Institute for Global Health UK , London ,","place":["UK"]},{"name":"Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bacal","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]},{"name":"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-750X","authenticated-orcid":false,"given":"Pedro A","family":"Lemos","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein , Av. Albert Einstein 627, S\u00e3o Paulo, SP 05652-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2026021011513195400_ehaf1050-B1","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021011513195400_ehaf1050-B2","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","article-title":"Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology","volume":"32","author":"Steg","year":"2011","journal-title":"Eur Heart J"},{"key":"2026021011513195400_ehaf1050-B3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","article-title":"Stopping aspirin within 1 month after stenting for ticagrelor monotherapy in acute coronary syndrome: the T-PASS randomized noninferiority trial","volume":"149","author":"Hong","year":"2024","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41569-023-00901-2","article-title":"De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a consensus statement from an international expert panel on coronary thrombosis","volume":"20","author":"Gorog","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026021011513195400_ehaf1050-B5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the Academic Research Consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/eurheartj\/ehac829","article-title":"Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis","volume":"44","author":"Kang","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021011513195400_ehaf1050-B7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(24)01616-7","article-title":"De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials","volume":"404","author":"Valgimigli","year":"2024","journal-title":"Lancet"},{"key":"2026021011513195400_ehaf1050-B8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamacardio.2024.3216","article-title":"Short-term dual antiplatelet therapy after drug-eluting stenting in patients with acute coronary syndromes: a systematic review and network meta-analysis","volume":"9","author":"Carvalho","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026021011513195400_ehaf1050-B9","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.jacc.2022.08.767","article-title":"Biomarker-based prediction of recurrent ischemic events in patients with acute coronary syndromes","volume":"80","author":"Batra","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021011513195400_ehaf1050-B10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2017.08.018","article-title":"Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI","volume":"70","author":"Giustino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021011513195400_ehaf1050-B11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMoa2507980","article-title":"Early withdrawal of aspirin after PCI in acute coronary syndromes","volume":"393","author":"Guimaraes","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021011513195400_ehaf1050-B12","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.4244\/EIJ-D-23-00125","article-title":"P2y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET trial","volume":"19","author":"Guimaraes","year":"2023","journal-title":"EuroIntervention"},{"key":"2026021011513195400_ehaf1050-B13","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y(12) receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B15","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.jacc.2019.08.1034","article-title":"Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week","volume":"74","author":"Gregson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026021011513195400_ehaf1050-B16","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"2026021011513195400_ehaf1050-B17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(20)31791-8","article-title":"Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial","volume":"396","author":"Kim","year":"2020","journal-title":"Lancet"},{"key":"2026021011513195400_ehaf1050-B18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026021011513195400_ehaf1050-B19","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0140-6736(24)00473-2","article-title":"Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial","volume":"403","author":"Ge","year":"2024","journal-title":"Lancet"},{"key":"2026021011513195400_ehaf1050-B20","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021011513195400_ehaf1050-B21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021011513195400_ehaf1050-B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4244\/EIJ-D-22-00886","article-title":"Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study","volume":"19","author":"van der Sangen","year":"2023","journal-title":"EuroIntervention"},{"key":"2026021011513195400_ehaf1050-B23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41569-022-00725-6","article-title":"P2y(12) inhibitor monotherapy in patients undergoing percutaneous coronary intervention","volume":"19","author":"Capodanno","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026021011513195400_ehaf1050-B24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.123.066720","article-title":"An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial","volume":"149","author":"Natsuaki","year":"2024","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B25","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa2508808","article-title":"Early discontinuation of aspirin after PCI in low-risk acute myocardial infarction","volume":"393","author":"Tarantini","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021011513195400_ehaf1050-B26","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.120.046534","article-title":"Risk\/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS","volume":"141","author":"Alexander","year":"2020","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B27","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"2026021011513195400_ehaf1050-B28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1056\/NEJMra1607714","article-title":"Management of antithrombotic therapy after acute coronary syndromes","volume":"384","author":"Rodriguez","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021011513195400_ehaf1050-B29","doi-asserted-by":"publisher","first-page":"e20240165","DOI":"10.36660\/abc.20240165","article-title":"Acute coronary syndrome in Brazil: registration of predisposing factors and population profile in a national public reference cardiological institute","volume":"122","author":"Nascimento","year":"2025","journal-title":"Arq Bras Cardiol"},{"key":"2026021011513195400_ehaf1050-B30","doi-asserted-by":"publisher","first-page":"e013057","DOI":"10.1161\/JAHA.119.013057","article-title":"Disparities in access and mortality of patients with ST-segment-elevation myocardial infarction using the Brazilian public healthcare system: VICTIM register","volume":"8","author":"Oliveira","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026021011513195400_ehaf1050-B31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/s0066-782(2013000100003","article-title":"Clinical outcomes at 30 days in the Brazilian registry of acute coronary syndromes (ACCEPT)","volume":"100","author":"Piva e Mattos","year":"2013","journal-title":"Arq Bras Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehaf1050\/66007327\/ehaf1050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehaf1050\/66007327\/ehaf1050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehaf1050\/66007327\/ehaf1050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:51:40Z","timestamp":1770742300000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehaf1050\/8383793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1050","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"ehaf1050"}}